187 related articles for article (PubMed ID: 1279965)
1. Finasteride for benign prostatic hyperplasia.
Hasinski S; Miller JL; Rose LI
Am Fam Physician; 1992 Nov; 46(5):1511-4. PubMed ID: 1279965
[TBL] [Abstract][Full Text] [Related]
2. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
Gormley GJ; Stoner E; Bruskewitz RC; Imperato-McGinley J; Walsh PC; McConnell JD; Andriole GL; Geller J; Bracken BR; Tenover JS
N Engl J Med; 1992 Oct; 327(17):1185-91. PubMed ID: 1383816
[TBL] [Abstract][Full Text] [Related]
3. New options for patients with benign prostatic hyperplasia.
Ellenberger B
CMAJ; 1993 Feb; 148(4):543-7. PubMed ID: 7679313
[No Abstract] [Full Text] [Related]
4. One-year experience in the treatment of benign prostatic hyperplasia with finasteride. The MK-906 (Finasteride) Study Group.
J Androl; 1991; 12(6):372-5. PubMed ID: 1722792
[TBL] [Abstract][Full Text] [Related]
5. Finasteride: the first 5 alpha-reductase inhibitor.
Sudduth SL; Koronkowski MJ
Pharmacotherapy; 1993; 13(4):309-25; discussion 325-9. PubMed ID: 7689728
[TBL] [Abstract][Full Text] [Related]
6. Finasteride: a 5 alpha-reductase inhibitor.
Steiner JF
Clin Pharm; 1993 Jan; 12(1):15-23. PubMed ID: 7679063
[TBL] [Abstract][Full Text] [Related]
7. Thoughts on finasteride for benign prostatic hyperplasia.
Anand A
Am Fam Physician; 1993 Sep; 48(4):582, 588. PubMed ID: 7691035
[No Abstract] [Full Text] [Related]
8. Is the prostate pill finally here?
Lange PH
N Engl J Med; 1992 Oct; 327(17):1234-6. PubMed ID: 1383817
[No Abstract] [Full Text] [Related]
9. Finasteride for benign prostatic hypertrophy.
Med Lett Drugs Ther; 1992 Sep; 34(878):83-4. PubMed ID: 1380630
[No Abstract] [Full Text] [Related]
10. [5-alpha reductase inhibitor in prostatic adenoma?].
Heinzl S
Med Monatsschr Pharm; 1990 Dec; 13(12):382-4. PubMed ID: 1705307
[No Abstract] [Full Text] [Related]
11. [Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia].
Botto H; Lan O; Poulain JE; Comenducci A
Prog Urol; 2005 Dec; 15(6):1090-5. PubMed ID: 16429658
[TBL] [Abstract][Full Text] [Related]
12. Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.
McConnell JD; Wilson JD; George FW; Geller J; Pappas F; Stoner E
J Clin Endocrinol Metab; 1992 Mar; 74(3):505-8. PubMed ID: 1371291
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment of benign prostatic hyperplasia.
Schmidt JD
West J Med; 1991 Dec; 155(6):633. PubMed ID: 1725942
[No Abstract] [Full Text] [Related]
14. The clinical development of a 5 alpha-reductase inhibitor, finasteride.
Stoner E
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):375-8. PubMed ID: 1701660
[TBL] [Abstract][Full Text] [Related]
15. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
Geller J
J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
[TBL] [Abstract][Full Text] [Related]
16. Effects of long term treatment with finasteride (MK-906), a 5-alpha reductase inhibitor, on circulating LH, FSH, prolactin and estradiol.
Matzkin H; Chen J; Lewyshon O; Ayalon D; Braf Z
Horm Metab Res; 1992 Oct; 24(10):498-9. PubMed ID: 1281461
[No Abstract] [Full Text] [Related]
17. The concentrations of the endogenous C19-steroids in hyperplastic prostatic tissue and the effect of finasteride treatment.
Hill M; Petrik R; Hampl R; Stárka L
Horm Metab Res; 1996 Oct; 28(10):562-4. PubMed ID: 8934217
[TBL] [Abstract][Full Text] [Related]
18. [Prostatic adenoma: new drugs, new surgical techniques].
Heinzl S
Med Monatsschr Pharm; 1992 Dec; 15(12):362-4. PubMed ID: 1282201
[No Abstract] [Full Text] [Related]
19. Finasteride for benign prostatic hyperplasia.
DuBeau CE
N Engl J Med; 1993 Feb; 328(6):443. PubMed ID: 7678439
[No Abstract] [Full Text] [Related]
20. A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.
Gisleskog PO; Hermann D; Hammarlund-Udenaes M; Karlsson MO
Clin Pharmacol Ther; 1998 Dec; 64(6):636-47. PubMed ID: 9871428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
